Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy

European Journal of Cancer

Volumn 44, Issue 12, 2008, Pages 1663-1669

  Oechsle, K ^a   Kollmannsberger, C ^b   Honecker, F ^a   Boehlke, I ^a   Bokemeyer, C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cerebral metastases; Germ cell tumour; High dose chemotherapy

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; PACLITAXEL;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LUNG METASTASIS; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUROSURGERY; NON SEMINOMATOUS GERMINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENCE RISK; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CISPLATIN; CLINICAL TRIALS, PHASE II AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 48249150001     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.05.012     Document Type: Article

References (20)

1. Birch R., Wiliams S., Cone A., et al. Prognostic factors for favourable out come in disseminated germ cell tumors. J Clin Oncol 4 (1996) 400-407
2. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15 (1997) 594-603
3. Einhorn L.H. Curing metastatic testicular cancer. Proc Nat Acad Sci USA 99 (2002) 4592-4595
4. Schmoll H.J., Kollmannsberger C., Metzner B., et al. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. J Clin Oncol 21 (2003) 4083-4091
5. Bokemeyer C., Kollmannsberger C., Meisner C., et al. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis. J Clin Oncol 17 (1999) 3450-3456
6. Bokemeyer C., Schleucher N., Metzner B., et al. First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial. Br J Cancer 89 (2003) 29-35
7. Hartmann J.T., Gauler T., Metzner B., et al. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. J Clin Oncol 25 (2007) 5742-5747
8. Motzer R.J., Nichols C.J., Margolin K.A., et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 25 (2007) 247-256
9. Fossa S.D., Bokemeyer C., Gerl A., et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 85 (1999) 988-997
10. Bokemeyer C., Nowak P., Haupt A., et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 15 (1997) 1449-1454
11. Spears W.T., Morphis II J.G., Lester S.G., Williams S.D., and Einhorn L.H. Brain metastases and testicular tumors: long-term survival. Int J Radiat Oncol Biol Phys 22 (1992) 17-22
12. Logothetis C.J., Samuels M.L., and Trindade A. The management of brain metastases in germ cell tumors. Cancer 49 (1982) 12-18
13. Rustin G.J., Newlands E.S., Bagshawe K.D., Begent R.H., and Crawford S.M. Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57 (1986) 2108-2113
14. Kollmannsberger C., Nichols C., Bamberg M., et al. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Ann Oncol 11 (2000) 553-559
15. Kobayashi T., Yoshida J., Ishiyama J., Noda S., Kito A., and Kida Y. Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study. J Neurosurg 70 (1989) 676-681
16. Azar J.M., Einhorn L.H., and Schneider B.P. Is the blood-brain barrier relevant in metastatic germ cell tumors?. Int J Radiat Oncol Biol Phys 69 (2007) 163-166
17. Buckner J.C., Peethambaram P.P., Smithson W.A., et al. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CM germ cell tumors. J Clin Oncol 17 (1999) 933-940
18. Raghavan D., Mackintosh J.F., Fox R.M., Rogers J., Duval P., and Besser M. Improved survival after brain metastases in non-seminomatous germ cell tumours with combined modality treatment. Br J Urol 60 (1987) 364-367
19. Salvati M., Piccirilli M., Raco A., et al. Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment. Neurosurg Rev 29 (2006) 130-137
20. Raina V., Singh S.P., Kamble N., et al. Brain metastasis as the site of relapse in germ cell tumor of testis. Cancer 72 (1993) 2182-2185